OPENING OF BANKRUPTCY

PERPHARM

Export PDF

Financial year 2022 · closed on 31/12/2022

Net result

-145,3 k €

-686.6% YoY

Gross margin

320,6 k €

-7.0% YoY

Equity

15,5 k €

-90.4% YoY

Workforce

7,7 ETP

+22.2% YoY

Company — Opening of bankruptcy.

What does PERPHARM do?

PERPHARM is a Public limited company incorporated in 2002. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Péruwelz. It employs on average 7,7 ETP workers (FTE).

Legal situation

● Opening of bankruptcy

BCE/KBO no. / VAT

BE 0478.611.658

Incorporation

17/10/2002

Legal form

Public limited company

Registered office

Rue Pont-à-la-Faulx(PER) 26-28
7600 Péruwelz · WallonieSee on map

Contributed capital

62 000,00 €

Latest accounts

31/12/2022

Average workforce

7,7 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

Healthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	320,6 k €	-7.0%	344,9 k €	+25.9%	274 k €	+11.5%	245,8 k €	+46.7%	167,6 k €	-11.6%	189,6 k €	-10.4%	211,7 k €	+5.9%	199,8 k €	-6.8%	214,4 k €	+7.1%	200,2 k €	+48.3%	135 k €	-18.4%	165,5 k €	+35.0%	122,6 k €	-35.2%	189,1 k €	+3.1%	183,4 k €	-17.9%	223,5 k €	+10.6%	202,1 k €
EBITDA	-40,6 k €	-142%	95,8 k €	-18.2%	117,2 k €	+25.8%	93,1 k €	+205%	30,6 k €	-46.9%	57,5 k €	-26.4%	78,2 k €	+1.3%	77,2 k €	-7.6%	83,5 k €	-2.2%	85,4 k €	+19.9%	71,2 k €	+26.3%	56,4 k €	+1263%	-4,8 k €	-104%	113,5 k €	-9.1%	124,8 k €	-7.2%	134,5 k €	+26.5%	106,3 k €
Operating result	-129,2 k €	-430%	39,2 k €	-40.4%	65,7 k €	+48.7%	44,2 k €	+376%	-16 k €	-132%	49,7 k €	-29.0%	70 k €	+2.6%	68,3 k €	-6.4%	72,9 k €	-7.3%	78,7 k €	+229%	23,9 k €	+430%	-7,3 k €	+89.4%	-68,5 k €	-232%	51,9 k €	-16.7%	62,3 k €	-10.5%	69,6 k €	+58.5%	43,9 k €
Net result	-145,3 k €	-687%	24,8 k €	-53.2%	53 k €	+35.6%	39,1 k €	+335%	-16,6 k €	-153%	31,1 k €	-30.6%	44,8 k €	-26.2%	60,6 k €	-13.4%	70 k €	-8.7%	76,7 k €	+325%	18 k €	+208%	-16,7 k €	+79.7%	-82,4 k €	-324%	36,7 k €	-15.9%	43,6 k €	-10.1%	48,5 k €	+125%	21,5 k €
Balance sheet
Equity	15,5 k €	-90.4%	160,8 k €	+18.2%	136 k €	-14.0%	158,2 k €	+32.8%	119,1 k €	-12.2%	135,7 k €	+29.7%	104,6 k €	+74.8%	59,9 k €	+35.4%	44,2 k €	+130%	19,2 k €	+133%	-57,5 k €	+23.9%	-75,5 k €	-28.4%	-58,8 k €	-350%	23,5 k €	+279%	-13,2 k €	+76.8%	-56,8 k €	+46.1%	-105,3 k €
Total assets	2 M €	+8.7%	1,9 M €	+111%	884 k €	+10.6%	799,3 k €	+21.8%	656,5 k €	+62.5%	404 k €	-2.6%	414,6 k €	-38.1%	670 k €	+1.0%	663,1 k €	+14.7%	578 k €	+25.0%	462,4 k €	-14.6%	541,7 k €	-4.0%	564,1 k €	-16.0%	671,3 k €	+0.1%	670,7 k €	-2.3%	686,3 k €	+2.5%	669,3 k €
Cash	173,6 k €	+428%	32,9 k €	-15.2%	38,8 k €	-4.0%	40,4 k €	+53.7%	26,3 k €	-81.7%	143,5 k €	+8.8%	131,8 k €	+13.9%	115,8 k €	-12.7%	132,5 k €	+30.0%	102 k €	+101%	50,7 k €	-38.3%	82,2 k €	-2.6%	84,4 k €	-30.9%	122,3 k €	+22.3%	100 k €	-5.9%	106,3 k €	+31.4%	80,9 k €
Debts	2 M €	+18.4%	1,7 M €	+127%	748 k €	+16.7%	641,2 k €	+19.4%	537,1 k €	+100%	268,3 k €	-13.5%	310 k €	-49.2%	610,2 k €	-1.4%	618,9 k €	+10.8%	558,7 k €	+7.5%	519,9 k €	-15.8%	617,2 k €	-0.9%	623 k €	-3.8%	647,7 k €	-5.3%	683,9 k €	-5.8%	726,3 k €	-3.8%	755 k €
Other
Workforce	7,7 ETP	+22.2%	6,3 ETP	+65.8%	3,8 ETP	+11.8%	3,4 ETP	0.0%	3,4 ETP	0.0%	3,4 ETP	-10.5%	3,8 ETP	+11.8%	3,4 ETP	0.0%	3,4 ETP	+9.7%	3,1 ETP	+10.7%	2,8 ETP	-6.7%	3,0 ETP	-18.9%	3,7 ETP	+118%	1,7 ETP	+6.2%	1,6 ETP	-30.4%	2,3 ETP	-23.3%	3,0 ETP

Governance

Board of directors

Seen on filing of 31/12/2022 · 1 active · 8 ended

Active mandates

RISSPHAR

Director · since 01 octobre 2018 · until 22 juin 2023 · 0678.429.579

Represented by Thibault RISSELIN

Active

Ended mandates

LUCILE JULIE MARGUET

Director · since 01 octobre 2018 · until 22 juin 2023

Ended

Lucile MARGUET

Director · since 01 octobre 2018 · until 29 novembre 2021

Ended

Lucile MARGUET

Director · since 01 octobre 2018 · until 22 juin 2023

Ended

RISSPHAR

Director · since 01 octobre 2018 · until 22 juin 2023 · 0678.429.579

Represented by Thibault RISSELIN

Ended

Annual accounts

Full financial information

	2022	2021	2020	2019	2018	2017
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2022	01/01/2021	01/01/2020	01/01/2019	01/01/2018	01/01/2017
Closing of the financial year	31/12/2022	31/12/2021	31/12/2020	31/12/2019	31/12/2018	31/12/2017
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	23/01/2024	12/07/2022	14/07/2021	24/08/2020	29/08/2019	30/08/2018
General meeting	01/12/2023	24/06/2022	25/06/2021	26/06/2020	28/06/2019	22/06/2018
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

17 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2022	01/12/2023	23/01/2024	French	PDF
Abridged model	31/12/2021	24/06/2022	12/07/2022	French	PDF
Abridged model	31/12/2020	25/06/2021	14/07/2021	French	PDF
Abridged model	31/12/2019	26/06/2020	24/08/2020	French	PDF
Abridged model	31/12/2018	28/06/2019	29/08/2019	French	PDF
Abridged model	31/12/2017	22/06/2018	30/08/2018	French	PDF
Abridged model	31/12/2016	23/06/2017	24/08/2017	French	PDF
Abridged model	31/12/2015	01/05/2016	31/08/2016	French	PDF
Abridged model	31/12/2014	22/08/2015	31/08/2015	French	PDF
Abridged model	31/12/2013	23/08/2014	29/08/2014	French	PDF
Abridged model	31/12/2012	24/08/2013	30/08/2013	French	PDF
Abridged model	31/12/2011	26/05/2012	20/08/2012	French	PDF
Abridged model	31/12/2010	28/05/2011	21/06/2011	French	PDF
Abridged model	31/12/2009	19/06/2010	09/07/2010	French	PDF
Abridged model	31/12/2008	18/07/2009	31/08/2009	French	PDF
Abridged model	31/12/2007	02/08/2008	26/08/2008	French	PDF
Abridged model	31/12/2006	26/05/2007	17/07/2007	French	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2022 · 1 active · 8 ended

Active mandates

RISSPHAR

Director · since 01 octobre 2018 · until 22 juin 2023 · 0678.429.579

Represented by Thibault RISSELIN

Active

Ended mandates

LUCILE JULIE MARGUET

Director · since 01 octobre 2018 · until 22 juin 2023

Ended

Lucile MARGUET

Director · since 01 octobre 2018 · until 29 novembre 2021

Ended

Lucile MARGUET

Director · since 01 octobre 2018 · until 22 juin 2023

Ended

RISSPHAR

Director · since 01 octobre 2018 · until 22 juin 2023 · 0678.429.579

Represented by Thibault RISSELIN

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other31/10/2023
DIVERS
PDF
Mandates31/07/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates23/10/2018
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Mandates12/01/2015
DEMISSIONS, NOMINATIONS
PDF
Capital / shares23/01/2012
CAPITAL, ACTIONS - ASSEMBLEE GENERALE
PDF
Mandates12/12/2011
DEMISSIONS, NOMINATIONS
PDF
Other14/04/2006
DIVERS
PDF
Other25/10/2002
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2022
Annual accounts 2022-145,3 k €↓
2021
Annual accounts 202124,8 k €↓
2020
Annual accounts 202053 k €↑
2019
Annual accounts 201939,1 k €↑
2018
Annual accounts 2018-16,6 k €↓
2017
Annual accounts 201731,1 k €↓
2016
Annual accounts 201644,8 k €↓
2015
Annual accounts 201560,6 k €↓
2014
Annual accounts 201470 k €↓
2013
Annual accounts 201376,7 k €↑
2012
Annual accounts 201218 k €↑
2011
Annual accounts 2011-16,7 k €↑
2010
Annual accounts 2010-82,4 k €↓
2009
Annual accounts 200936,7 k €↓
2008
Annual accounts 200843,6 k €↓
2007
Annual accounts 200748,5 k €↑
2006
Annual accounts 200621,5 k €
17/10/2002
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PERPHARM

Overview

What does PERPHARM do?

Trend over 17 financial years

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline